626 related articles for article (PubMed ID: 12474051)
1. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
[TBL] [Abstract][Full Text] [Related]
2. Nm23-H1 expression does not predict clinical survival in colorectal cancer patients.
Dusonchet L; Corsale S; Migliavacca M; Calò V; Bazan V; Amato A; Cammareri P; Totaro MS; Agnese V; Cascio S; La Rocca G; Sisto PS; Dardanoni G; Valerio MR; Grassi N; Latteri S; Cajozzo M; Buscemi M; Castorina S; Morello V; Tomasino RM; Gebbia N; Russo A
Oncol Rep; 2003; 10(5):1257-63. PubMed ID: 12883690
[TBL] [Abstract][Full Text] [Related]
3. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
Alderisio M; Cenci M; Valli C; Russo A; Bazan V; Dardanoni G; Cucciarre S; Carreca I; Macaluso MP; Tomasino RM; Vecchione A
Anticancer Res; 1998; 18(6A):4225-30. PubMed ID: 9891471
[TBL] [Abstract][Full Text] [Related]
4. p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: a prospective study with a five-year follow-up.
Russo A; Migliavacca M; Zanna I; Valerio MR; Latteri MA; Grassi N; Pantuso G; Salerno S; Dardanoni G; Albanese I; La Farina M; Tomasino RM; Gebbia N; Bazan V
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1322-31. PubMed ID: 12433709
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma.
Russo A; Bazan V; Migliavacca M; Zanna I; Tubiolo C; Tumminello FM; Dardanoni G; Cajozzo M; Bazan P; Modica G; Latteri M; Tomasino RM; Colucci G; Gebbia N; Leto G
Clin Cancer Res; 2000 Jan; 6(1):178-84. PubMed ID: 10656448
[TBL] [Abstract][Full Text] [Related]
6. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
[TBL] [Abstract][Full Text] [Related]
7. TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma.
Russo A; Corsale S; Agnese V; Macaluso M; Cascio S; Bruno L; Surmacz E; Dardanoni G; Valerio MR; Vieni S; Restivo S; Fulfaro F; Tomasino RM; Gebbia N; Bazan V
J Cell Physiol; 2006 Jan; 206(1):181-8. PubMed ID: 15965904
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of nm23-H1 in stage I non-small cell lung cancer: a useful marker in prediction of metastases.
Lai WW; Wu MH; Yan JJ; Chen FF
Ann Thorac Surg; 1996 Nov; 62(5):1500-4. PubMed ID: 8893591
[TBL] [Abstract][Full Text] [Related]
9. The prediction of lymph node metastases in colorectal cancer by expression of the nucleoside diphosphate kinase/nm23-H1 and histopathological variables.
Tannapfel A; Katalinic A; Köckerling F; Wittekind C
Am J Gastroenterol; 1997 Jul; 92(7):1182-6. PubMed ID: 9219795
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of NDP kinase nm23 associated with ploidy image analysis in colorectal cancer.
Giarnieri E; Alderisio M; Valli C; Vecchione A; Forte A; Turano R; Pulcini M
Anticancer Res; 1995; 15(5B):2049-53. PubMed ID: 8572601
[TBL] [Abstract][Full Text] [Related]
11. Correlates of urokinase-type plasminogen activator in colorectal cancer: positive relationship with nm23 and c-erbB-2 protein expression.
Berney CR; Yang J; Fisher RJ; Russell PJ; Crowe PJ
Oncol Res; 1998; 10(1):47-54. PubMed ID: 9613457
[TBL] [Abstract][Full Text] [Related]
12. Analysis of both NM23-h1 and NM23-H2 expression identifies "at-risk" patients with colorectal cancer.
Brenner AS; Thebo JS; Senagore AJ; Duepree HJ; Gramlich T; Ormsby A; Lavery IC; Fazio VW
Am Surg; 2003 Mar; 69(3):203-8; discussion 208. PubMed ID: 12678475
[TBL] [Abstract][Full Text] [Related]
13. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver.
Sarris M; Lee CS
Eur J Surg Oncol; 2001 Mar; 27(2):170-4. PubMed ID: 11289754
[TBL] [Abstract][Full Text] [Related]
14. Expression of nm23-H1 in transitional cell carcinoma of the upper urinary tract.
Cheng HL; Tong YC; Tzai TS; Weng CL; Ho CL; Yang WH; Lin JS; Chow NH
Oncol Rep; 2001; 8(1):193-6. PubMed ID: 11115597
[TBL] [Abstract][Full Text] [Related]
15. Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin.
Heimann R; Lan F; McBride R; Hellman S
Cancer Res; 2000 Jan; 60(2):298-304. PubMed ID: 10667580
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic markers of the epithelial tumors of the large intestine].
Forte A; D'Urso A; Gallinaro LS; Lo Storto G; Covotta A; Soda G; Bosco D; Nardoni S; Bezzi M; Beltrami V
Ann Ital Chir; 2002; 73(6):587-96; discussion 597. PubMed ID: 12820582
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
Garrity MM; Burgart LJ; Mahoney MR; Windschitl HE; Salim M; Wiesenfeld M; Krook JE; Michalak JC; Goldberg RM; O'Connell MJ; Furth AF; Sargent DJ; Murphy LM; Hill E; Riehle DL; Meyers CH; Witzig TE;
J Clin Oncol; 2004 May; 22(9):1572-82. PubMed ID: 15117979
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer.
Lundin J; Nordling S; von Boguslawsky K; Roberts PJ; Haglund C
Anticancer Res; 1995; 15(6B):2659-68. PubMed ID: 8669843
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the prognostic value of a panel of tissue tumor markers and established clinicopathological factors in patients with gastric cancer.
Wiksten JP; Lundin J; Nordling S; Kokkola A; Haglund C
Anticancer Res; 2008; 28(4C):2279-87. PubMed ID: 18751407
[TBL] [Abstract][Full Text] [Related]
20. Allelic imbalance at NME1 in microdissected primary and metastatic human colorectal carcinomas is frequent but not associated with metastasis to lymph nodes or liver.
Lamb RF; Going JJ; Pickford I; Birnie GD
Cancer Res; 1996 Feb; 56(4):916-20. PubMed ID: 8631033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]